# Study of Occipital Nerve Stimulation for Drug Refractory Migraine

> **NCT00747812** · PHASE2 · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 11 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Precision

## Key facts

- **NCT ID:** NCT00747812
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2008-11
- **Final completion:** 2012-05
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Sponsor closed enrollment early based on interim data from the PRISM US Pivotal Study.
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747812, "Study of Occipital Nerve Stimulation for Drug Refractory Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00747812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*